Mark M Awad1, Peter S Hammerman2. Show Affiliations » 1. Dana-Farber Cancer Institute, Boston, MA. 2. Dana-Farber Cancer Institute, Boston, MA peter_hammerman@dfci.harvard.edu.
Abstract
Entities: Disease
Mesh: See more » Antibodies, Monoclonal/administration & dosageAntibodies, Monoclonal/therapeutic useAntineoplastic Agents/administration & dosageCarcinoma, Non-Small-Cell Lung/drug therapyCarcinoma, Renal Cell/drug therapyFemaleHumansKidney Neoplasms/drug therapyLung Neoplasms/drug therapyMale
Substances: See more » Antibodies, MonoclonalAntineoplastic Agents
Year: 2015 PMID: 25918290 DOI: 10.1200/JCO.2015.61.4172
Source DB: PubMed Journal: J Clin Oncol ISSN: 0732-183X Impact factor: 44.544